Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Steurbaut, Stephane" or (type any "bookEditor journalEditor issueEditor" and editor="Steu...

Add to list
- Journal Article
- A1
- open access
Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation : a nationwide cohort study

Maxim Grymonprez (UGent) , Mirko Petrovic (UGent) , Tine De Backer (UGent) , Stephane Steurbaut and Lies Lahousse (UGent)

(2023) EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES.
Add to list
Non-vitamin K antagonist oral anticoagulants (NOACs) versus warfarin in patients with atrial fibrillation using P-gp and/or CYP450-interacting drugs : a systematic review and meta-analysis

Maxim Grymonprez (UGent) , Kevin Vanspranghe, Stephane Steurbaut, Tine De Backer (UGent) and Lies Lahousse (UGent)

(2023) CARDIOVASCULAR DRUGS AND THERAPY.
Add to list
- Journal Article
- A2
- open access
Clinical outcomes in patients with atrial fibrillation and a history of falls using non-vitamin K antagonist oral anticoagulants : a nationwide cohort study

Maxim Grymonprez (UGent) , Mirko Petrovic (UGent) , Tine De Backer (UGent) , Stephane Steurbaut and Lies Lahousse (UGent)

(2023) IJC HEART & VASCULATURE. 47.
Add to list
- Journal Article
- A1
- open access
Comparing the risk of dementia in subjects with atrial fibrillation using non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists : a Belgian nationwide cohort study

Maxim Grymonprez (UGent) , Mirko Petrovic (UGent) , Tine De Backer (UGent) , M Arfan Ikram, Stephane Steurbaut and Lies Lahousse (UGent)

(2023) AGE AND AGEING. 52(3).
Add to list
- Journal Article
- A1
- open access
Non-vitamin K antagonist oral anticoagulants (NOACs) versus warfarin in patients with atrial fibrillation and (morbid) obesity or low body weight : a systematic review and meta-analysis

Maxim Grymonprez (UGent) , Tine De Backer (UGent) , Stephane Steurbaut, Koen Boussery (UGent) and Lies Lahousse (UGent)

(2022) CARDIOVASCULAR DRUGS AND THERAPY. 36(4). p.749-761
Add to list
Worldwide trends in oral anticoagulant use in patients with atrial fibrillation from 2010 to 2018 : a systematic review and meta-analysis

Maxim Grymonprez (UGent) , Cynthia Simoens, Stephane Steurbaut, Tine De Backer (UGent) and Lies Lahousse (UGent)

(2022) EUROPACE. 24(6). p.887-898
Add to list
- Journal Article
- A1
- open access
Impact of P-glycoprotein and/or CYP3A4-interacting drugs on effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation : a meta-analysis

Maxim Grymonprez (UGent) , Kevin Vanspranghe, Andreas Capiau (UGent) , Koen Boussery (UGent) , Stephane Steurbaut and Lies Lahousse (UGent)

(2022) BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 88(7). p.3039-3051
Add to list
- Journal Article
- A1
- open access
Adherence and persistence to oral anticoagulants in patients with atrial fibrillation : a Belgian nationwide cohort study

Maxim Grymonprez (UGent) , Andreas Capiau (UGent) , Stephane Steurbaut, Els Mehuys (UGent) , Koen Boussery (UGent) , Tine De Backer (UGent) and Lies Lahousse (UGent)

(2022) FRONTIERS IN CARDIOVASCULAR MEDICINE. 9.
Add to list
Niet-vitamine K-antagonist orale anticoagulantia bij oudere patiënten met voorkamerfibrillatie

Maxim Grymonprez (UGent) , Stephane Steurbaut, Tine De Backer (UGent) , Mirko Petrovic (UGent) and Lies Lahousse (UGent)

(2021) TIJDSCHRIFT VOOR CARDIOLOGIE. 33(3). p.11-15
Add to list
- Journal Article
- A1
- open access
The impact of underweight and obesity on outcomes in anticoagulated patients with atrial fibrillation : a systematic review and meta‐analysis on the obesity paradox

Maxim Grymonprez (UGent) , Andreas Capiau (UGent) , Tine De Backer (UGent) , Stephane Steurbaut, Koen Boussery (UGent) and Lies Lahousse (UGent)

(2021) CLINICAL CARDIOLOGY. 44(5). p.599-608

Academic Bibliography

Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation : a nationwide cohort study

Non-vitamin K antagonist oral anticoagulants (NOACs) versus warfarin in patients with atrial fibrillation using P-gp and/or CYP450-interacting drugs : a systematic review and meta-analysis

Clinical outcomes in patients with atrial fibrillation and a history of falls using non-vitamin K antagonist oral anticoagulants : a nationwide cohort study

Comparing the risk of dementia in subjects with atrial fibrillation using non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists : a Belgian nationwide cohort study

Non-vitamin K antagonist oral anticoagulants (NOACs) versus warfarin in patients with atrial fibrillation and (morbid) obesity or low body weight : a systematic review and meta-analysis

Worldwide trends in oral anticoagulant use in patients with atrial fibrillation from 2010 to 2018 : a systematic review and meta-analysis

Impact of P-glycoprotein and/or CYP3A4-interacting drugs on effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation : a meta-analysis

Adherence and persistence to oral anticoagulants in patients with atrial fibrillation : a Belgian nationwide cohort study

Niet-vitamine K-antagonist orale anticoagulantia bij oudere patiënten met voorkamerfibrillatie

The impact of underweight and obesity on outcomes in anticoagulated patients with atrial fibrillation : a systematic review and meta‐analysis on the obesity paradox

Contents

Support

Contact